Application value of neutrophil gelatinase-associated lipocalin in diagnosing renal anemia and evaluating condition of disease

LI Xiaoliang; ZHANG Li

doi:10.7619/jcmp.20221625

Journal of Clinical Medicine in Practice > 2022 > 26(18): 83-86. > DOI: 10.7619/jcmp.20221625

LI Xiaoliang, ZHANG Li. Application value of neutrophil gelatinase-associated lipocalin in diagnosing renal anemia and evaluating condition of disease[J]. Journal of Clinical Medicine in Practice, 2022, 26(18): 83-86. DOI: 10.7619/jcmp.20221625

Citation:

PDF (784 KB)

Application value of neutrophil gelatinase-associated lipocalin in diagnosing renal anemia and evaluating condition of disease

LI Xiaoliang¹,
ZHANG Li^2, ,

1.
Department of Blood Transfusion, Chaohu Hospital Affiliated to Anhui Medical University, Chaohu, Anhui, 238001
2.
Molecular Diagnosis Group, Jiangsu Provincial Center for Disease Control, Nanjing, Jiangsu, 210009

More Information

Received Date: May 22, 2022
Available Online: October 23, 2022

Graphical Abstract

Abstract

Abstract

Objective
To explore the application value of blood neutrophil gelatinase-associated lipocalin (NGAL) in diagnosing renal anemia and evaluating condition of disease.
Methods
A total of 86 patients with chronic kidney disease (CKD) complicated with anemia were selected as research objects, and they were divided into mild group [hemoglobin (Hb)≥90 g/L] with 54 cases and moderate to severe group (Hb < 90 g/L) with 32 cases according to the degree of anemia. Another 36 CKD patients without anemia in the same period were selected as control group. The levels of red blood cell (RBC), hematocrit (HCT), Hb, blood NGAL, serum creatinine (Scr) and blood urea nitrogen (BUN) were compared among groups; the correlations between blood NGAL and various indexes were analyzed; the value of NGAL in diagnosis of renal anemia was analyzed by receiver operating characteristic (ROC) curve.
Results
The levels of blood NGAL, Scr and BUN in the moderate to severe group were significantly higher than those in the mild group and the control group, and the levels of blood NGAL, Scr and BUN in the mild group were significantly higher than those in the control group (P < 0.05). Spearman correlation analysis showed that blood NGAL in CKD patients complicated with anemia was significantly negatively correlated with RBC, HCT and Hb (P < 0.05), and positively correlated with Scr and BUN (P < 0.05). ROC curve analysis showed that the area under the curve (AUC) of blood NGAL level in the diagnosis of renal anemia was 0.729, the sensitivity was 80.2% (95%CI, 70.6 to 87.3), the specificity was 61.1% (95%CI, 44.9 to 75.2), and the optimal cut-off value was 134.62ng/mL.
Conclusion
The level of blood NGAL is closely related to the severity of renal anemia, and dynamic monitoring of blood NGAL level can provide reference for clinical diagnosis and disease evaluation of patients with renal anemia.
- neutrophil gelatinase-associated lipocalin,
- chronic kidney disease,
- renal anemia,
- hemoglobin,
- renal function

FullText(HTML)

References (18)

References

[1]	余雯枫, 余毅. 肾性贫血的诊治进展[J]. 世界临床药物, 2018, 39(3): 211-216, 19. https://www.cnki.com.cn/Article/CJFDTOTAL-GWHH201803017.htm
[2]	李博睿. 非透析慢性肾脏病贫血患者的生存质量评估[D]. 长春: 吉林大学, 2017.
[3]	车春红, 朱国贞. NGAL与肾脏疾病相关性的研究进展[J]. 生命科学, 2019, 31(1): 99-105. https://www.cnki.com.cn/Article/CJFDTOTAL-SMKX201901016.htm
[4]	汪杨, 魏日胞. 慢性肾脏病肾性贫血的基础与临床研究现状及进展[J]. 中国中西医结合肾病杂志, 2019, 20(5): 452-455. https://www.cnki.com.cn/Article/CJFDTOTAL-JXSB201905029.htm
[5]	中国医师协会肾脏内科医师分会肾性贫血指南工作组. 中国肾性贫血诊治临床实践指南[J]. 中华医学杂志, 2021, 101(20): 1463-1502. https://www.cnki.com.cn/Article/CJFDTOTAL-SZBY200106012.htm
[6]	付蓉, 江汇涓. 常见贫血临床诊断流程[J]. 中国实用内科杂志, 2015, 35(8): 691-695. https://www.cnki.com.cn/Article/CJFDTOTAL-SYNK201508014.htm
[7]	MCMURRAY J, PS P. KDIGO clinical practice guideline for Anemia in chronic kidney disease[J]. Kidney Int Suppl, 2012, 2(4): 1-335. https://boris.unibe.ch/13943/
[8]	沈海燕, 刘孝琴. 肾性贫血机制和治疗的研究进展[J]. 现代医药卫生, 2022, 38(1): 81-85. https://www.cnki.com.cn/Article/CJFDTOTAL-XYWS202201018.htm
[9]	LI Y, SHI H, WANG W M, et al. Prevalence, awareness, and treatment of Anemia in Chinese patients with nondialysis chronic kidney disease: first multicenter, cross-sectional study[J]. Medicine, 2016, 95(24): e3872.
[10]	SILVERBERG D S, WEXLER D, BLUM M, et al. Erythropoietin should be part of congestive heart failure management[J]. Kidney Int Suppl, 2003(87): S40-S47. https://www.sciencedirect.com/science/article/pii/S0085253815496413
[11]	LALMANE A, BEAUDEUX J L, BERNARD M A. NGAL: a biomarker of acute and chronic renal dysfunction[J]. Annales De Biologie Clinique, 2011, 69(6): 629-636.
[12]	DEVIREDDY L R, TEODORO J G, RICHARD F A, et al. Induction of apoptosis by a secreted lipocalin that is transcriptionally regulated by IL-3 deprivation[J]. Science, 2001, 293(5531): 829-834.
[13]	BOLIGNANO D, COPPOLINO G, DONATO V, et al. Neutrophil gelatinase-associated lipocalin (NGAL): a new piece of the Anemia puzzle[J]. Med Sci Monit, 2010, 16(6): RA131-RA135. doi: 10.1007/s00467-009-1397-1
[14]	BRAMHAM K, SEED P T, LIGHTSTONE L, et al. Diagnostic and predictive biomarkers for pre-eclampsia in patients with established hypertension and chronic kidney disease[J]. Kidney Int, 2016, 89(4): 874-885. https://www.sciencedirect.com/science/article/pii/S0085253815001271
[15]	YIN P, WU Q, SHOU L H, et al. Risk factors for Anemia in patients with chronic kidney disease: a protocol for systematic review and meta-analysis[J]. Medicine, 2021, 100(40): e27371.
[16]	ROSSERT J, FROISSART M. Role of Anemia in progression of chronic kidney disease[J]. Semin Nephrol, 2006, 26(4): 283-289. https://www.sciencedirect.com/science/article/pii/S0270929506000702
[17]	YANG H N, BOO C S, KIM M G, et al. Urine neutrophil gelatinase-associated lipocalin: an independent predictor of adverse outcomes in acute kidney injury[J]. Am J Nephrol, 2010, 31(6): 501-509. https://koreauniv.pure.elsevier.com/en/publications/urine-neutrophil-gelatinase-associated-lipocalin-an-independent-p
[18]	沈漪萍, 沈轩宇. 糖尿病肾病患者血清ACA、IL-6、NGAL水平变化及意义[J]. 山东医药, 2019, 59(4): 23-26. https://www.cnki.com.cn/Article/CJFDTOTAL-SDYY201904007.htm

[1]	CHANG Ailing, ZHAI Yaran, WANG Yujin, ZHANG Jincheng, WANG Fangzhen. Effect of dapagliflozin on vascular function and renal function of patients with diabetic nephropathy[J]. Journal of Clinical Medicine in Practice, 2024, 28(10): 78-82. DOI: 10.7619/jcmp.20234180
[2]	LI Bingyu, SHI Yong, CHEN Jiahui, LIANG Yalin, TANG Qian, YANG Qingyan. Correlations of serum Apelin-13 and Omentin-1 expression with renal function in patients after renal transplantation[J]. Journal of Clinical Medicine in Practice, 2023, 27(20): 6-10, 15. DOI: 10.7619/jcmp.20231525
[3]	SUN Yanting, WU Wei, WU Sisi, XUE Rongliang. Effects of sevoflurane on renal function and endothelial nitric oxide synthase of rats with renal ischemia reperfusion injury[J]. Journal of Clinical Medicine in Practice, 2021, 25(24): 104-108. DOI: 10.7619/jcmp.20211999
[4]	XU Xiaowen, LI Yuanyuan. Effect of ω-3 fish oil fat emulsion on postoperative liver and renal functions and prognosis in patients with gastric cancer[J]. Journal of Clinical Medicine in Practice, 2021, 25(20): 42-45, 51. DOI: 10.7619/jcmp.20213527
[5]	CHANG Xiangrong, DANG Shuangsuo, JIANG Ce. Influences of three nucleotide drugs on renal function of patients with chronic hepatitis B and intervention effect of telbivudine on renal function injury caused by adefovir dipivoxil[J]. Journal of Clinical Medicine in Practice, 2020, 24(12): 87-92. DOI: 10.7619/jcmp.202012025
[6]	WEI Jianqiang, NIU Huaiying. Significance of coagulation function and glycosylated hemoglobin in judging the progression of diabetes[J]. Journal of Clinical Medicine in Practice, 2019, 23(22): 61-63. DOI: 10.7619/jcmp.201922021
[7]	SONG Hongbo, LI Yanping, KANG Li, JIA Xiaozhou, WANG Fenglan, ZHANG Chen, LI Xueting. Effect of albumin combined with plasma transfusionon duration of shock and renal function in patients with hemorrhagic fever shock with renal syndrome[J]. Journal of Clinical Medicine in Practice, 2019, 23(22): 34-36, 39. DOI: 10.7619/jcmp.201922012
[8]	LI Jian, WANG Min, TIAN Chuan. Effects of terlipressin combined with alprostadil on hepatic and renal function in liver cirrhosis patients with refractory ascites[J]. Journal of Clinical Medicine in Practice, 2018, (5): 39-41,44. DOI: 10.7619/jcmp.201805012
[9]	HE Dejiao, LING Na, WU Hong. Application and nursing of combined artificial kidney in patients with chronic renal failure[J]. Journal of Clinical Medicine in Practice, 2017, (8): 55-57. DOI: 10.7619/jcmp.201708017
[10]	LIU Xiangru, WANG Caian, TANG Chunshi, LI Shihuang, XIAO Kan, PENG Lu, CHEN Chaoxiong. Influence of nifedipine controlled release tablets combined with indapamide on renal function of elderly patients with refractory isolated systolic hypertension[J]. Journal of Clinical Medicine in Practice, 2014, (7): 79-80,93. DOI: 10.7619/jcmp.201407025

Cited By

Cited by

Periodical cited type(11)

1.	吴丽云. 行为转变理论护理模式加呼吸康复训练对慢性阻塞性肺疾病稳定期患者肺功能及呼吸困难的改善效果. 中国医药指南. 2024(10): 165-167 .
2.	李佳，茅红霞，张赛丽. 四级锻炼结合集束化干预对AECOPD机械通气患者血气指标及呼吸力学参数的影响. 全科医学临床与教育. 2024(04): 330-335 .
3.	罗秀华. 肺功能康复训练对COPD稳定期患者生活质量和肺功能的影响研究. 中国现代药物应用. 2024(08): 177-180 .
4.	张一虹，许胜. 进阶式抗阻运动结合呼吸康复锻炼对老年COPD稳定期患者肺功能、运动耐力和生活质量的影响. 中国老年学杂志. 2024(13): 3116-3119 .
5.	王芳，许檬，李媛媛. 双向质量反馈护理模式在老年慢性阻塞性肺疾病患者中的应用效果及对其生存质量的影响分析. 中外医疗. 2024(26): 166-169 .
6.	张明，王娇. 神经肌肉电刺激在慢性阻塞性肺疾病康复中的应用效果. 深圳中西医结合杂志. 2024(18): 116-119 .
7.	白黎峰，张倩. 不同频率反馈式呼吸电刺激训练促进中重度COPD稳定期患者的康复效果对比. 河南医学研究. 2023(10): 1827-1831 .
8.	饶丽仙，黄晨娟，黄彩珠，曾文君. 中药穴位贴敷、穴位艾灸联合肺康复训练在慢性阻塞性肺疾病患者中的应用. 中国医学创新. 2023(21): 129-133 .
9.	李杏梨. 呼吸康复护理对慢阻肺患者生活质量及肺功能指标的影响. 人人健康. 2023(11): 102-104 .
10.	曹俊霞，王蓉，郭晓娟，高伟，王庆，郑军，陆娟，朱庆捷，史甜，刘菲，吴书清，曹柳兆，滕为云. 新型康复器具联合呼吸肌训练在结缔组织相关性间质性肺病患者中的应用. 实用临床医药杂志. 2023(17): 5-12 . 本站查看
11.	薛欠欠，陈长浩，李方梅，于秀梅，司肖肖，杨燕. 团体生物反馈法对残留型精神分裂症患者的疗效. 实用临床医药杂志. 2023(22): 95-99 . 本站查看

Other cited types(1)

Get Citation

PDF

XML

Article views (131) PDF downloads (2) Cited by(12)

Turn off MathJax

Article Contents

Abstract

References

Application value of neutrophil gelatinase-associated lipocalin in diagnosing renal anemia and evaluating condition of disease